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Abstract. We studied the expression of the N-myc 
proto-oncogene and the insulin-like growth factor-II 
(IGF-II) gene in human fetuses of 16-19 gestational 
wk. Both genes have specific roles in the growth and 
differentiation of embryonic tissues, such as the kid- 
ney and neural tissue.  Since continued expression of 
N-myc and IGF-II mRNAs is also a characteristic  fea- 
ture of Wilms' tumor,  a childhood neoplasm of proba- 
ble fetal kidney origin,  we were particularly interested 
in the possibility that their expression might be linked 
or coordinately regulated in the developing kidney. Ex- 
pression of N-myc mRNA was observed in the brain 
and in the kidney by Northern hybridization analysis. 
In in situ hybridization of the kidney, N-myc autora- 
diographic grains were primarily located over epitheli- 
ally differentiating mesenchyme while most of the 
mesenchymal stromal cells showed only a background 
signal with the N-myc probe. N-myc mRNA was de- 
tectable throughout the developing brain with a  slight 
accentuation in the intermediate zone cells in between 
the subependymal and cortical layers.  Thus,  even post- 
mitotic neuroepithelial  cells of the fetal cerebrum ex- 
pressed N-myc mRNA.  In Northern hybridization, 
IGF-II mRNA signal was abundant in the kidney but 
much weaker, though definite,  in the brain.  The re- 
gional distribution of IGF-II mRNA in the kidney was 
largely complementary to that of N-myc. IGF-II auto- 
radiographic grains were located predominantly over 
the stromal and blastemal cells with a  relative lack of 
hybridization over the epithelial  structures.  In the 
brain,  IGF-II mRNA was about two- to threefold more 
abundant in the subependymal and intermediate layers 
than  in the cortical plate and ependymal zone, respec- 
tively.  The fetal expression patterns of the N-myc and 
IGF-II mRNAs are reflected by the types of tumors 
known to express the corresponding genes during post- 
natal life such as Wilms' tumor.  However, the apparent 
coexpression of the IGF-II and N-myc genes in imma- 
ture kidneys occurs largely in distinct cell types. 
CORDING to prevailing theories  and experimental  evi- 
dence, proto-oncogenes and growth  factors are be- 
lieved to play key roles in the growth and differen- 
tiation  of embryonic tissues  (Wagner  and  Miiller,  1986; 
Adamson, 1987). Thus, expression of some proto-oncogenes 
and growth factor genes reaches a peak in early development 
and ceases before or shortly after birth.  A failure of repres- 
sion,  as well as later reactivation  of these genes (e.g., as a 
result of chromosomal translocation,  deletion,  point muta- 
tion, or amplification),  has been suggested to have a role in 
preventing the terminal  differentiation  of cells and allowing 
for their  continued  proliferation  (for reviews,  see Klein, 
1987; Bishop,  1987; Kahn and Graf,  1986). 
The myc family of cellular proto-oncogenes consists  of 
three known members, the c-myc, N-myc, and L-myc genes, 
that are believed to regulate  cell growth and differentiation 
(Alt et al.,  1986). High expression  of the myc genes is fre- 
quently found in a wide variety of human tumors (Alt et al., 
1986;  Alitalo  and  Schwab,  1986).  All myc genes are ex- 
pressed in embryonic and fetal tissues,  but distinct  tissue- 
and stage-specific expression patterns are observed (Pfeifer- 
Ohlsson et al.,  1985; Jakobovits et al.,  1985; Zimmerman 
et al.,  1986).  This suggests that the differential  expression 
of the myc genes  may  have  a  role in  regulating  multiple 
differentiation  pathways. The N-myc proto-oncogene codes 
for a nuclear phosphoprotein  of yet unknown function  (Ike- 
gaki et al., 1986; M~ikel~i et al., 1989; Ramsay et al., 1986; 
Slamon et al.,  1986). The gene was originally  identified as 
an amplified,  c-myc homologous DNA fragment in neuro- 
blastoma cell lines (Schwab et al., 1983; Kohl et al., 1983), 
and it has been shown to have a structural  organization  and 
a  protein  product  similar  to  c-myc (Kohl  et  al.,  1986; 
Schwab,  1986; Stanton et al.,  1986). 
In mice, the N-myc gene is active in various fetal tissues, 
predominantly  in the brain and in the kidney, the expression 
ceasing shortly after birth (Jakobovits et al., 1985; Zimmer- 
man et al., 1986). In human fetal kidney, the overall expres- 
sion of N-myc mRNA has been reported to decrease during 
17-21 gestational  weeks (Alt et al.,  1986).  In human fetal 
brain, N-myc mRNA was found to be expressed by both mi- 
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seen in differentiated neurons (Grady et al.,  1987).  High 
N-myc expression was also found in tumors displaying neu- 
roectodermal characteristics such as neuroblastomas, retino- 
blastomas,  and small cell lung cancer (Lee et al.,  1984; 
Schwab  et al.,  1984;  Kohl et al.,  1984;  Nau et al.,  1986; 
Wong et al., 1986).  In neuroblastomas, amplification of the 
N-myc gene, present in ~50% of stage III-IV tumors, pre- 
dicts a poor prognosis, independently of any other staging 
criteria (Brodeur et al., 1984; Seeger et al., 1985). Sporadic 
amplification of N-myc has been reported in, for example, a 
rhabdomyosarcoma and a lung adenocarcinoma (Garson et 
al.,  1986;  Saksela et al.,  1986).  Interestingly, the unam- 
plified N-myc gene is highly expressed in Wilms' tumors 
originating from nephrogenic blastemal cells (Nisen et al., 
1986). 
IGF-II is a member of a family of peptides related to insu- 
lin by structure and function. It is synthesized by many fetal 
tissues (Brown et al., 1986) and may be involved in growth 
stimulation in the fetus. IGF-II can be detected even in adult 
human cerebrospinal fluid and brain, suggesting a physiolog- 
ical role of  IGF-II in the central nervous system (Haselbacher 
and Humbel, 1982; Haselbacher et al., 1985).  However, no 
IGF-II mRNA was detected by in situ hybridization with oli- 
gonucleotide probes in human and on rat fetal neural tissues 
(Beck et al., 1987; Han et al., 1987). Transcripts of the IGF- 
II gene are relatively abundant in the kidney, adrenal, liver, 
and striated muscle taken from first-trimester human fetuses 
(Scott et al., 1985; Han et al., 1987). The expression oflGF- 
II mRNA in these tissues decreases until birth.  However, 
high levels of IGF-II expression, comparable to that in the 
fetal kidney, have been detected in Wilms' tumors (Reeve et 
al., 1985; Scott et al., 1985; Haselbacher et al., 1987). The 
IGF-II gene has been mapped to chromosomal band llp15 
(Brissenden et al., 1984;  Tricoli et al.,  1984;  Reeve et al., 
1985).  This  finding  is  particularly  interesting,  because 
Wilms' tumors apparently carry a recessive oncogene in the 
adjacent chromosomal band llp13, and a germline deletion 
of this band may correspond to one of the two mutations 
needed for the development of the tumor (Francke et al., 
1979;  Ladda et al.,  1974; Riccardi et al.,  1980;  Koufos et 
al.,  1985). 
We were interested in comparing the expression of N-myc 
and IGF-II genes in the kidney and the central nervous sys- 
tem, the two embryonic tissues where their specific roles in 
growth and differentiation and their deregulation have been 
implicated. Especially, we wanted to know, whether the spa- 
tial expression patterns of these genes could be coordinate 
and linked to cellular differentiation. For this purpose, we 
used Northern and in situ hybridization to analyze the tissue-, 
cell-,  and differentiation-specific expression of the N-myc 
and IGF-II mRNAs in fetal human tissues. 
Materials and Methods 
Fetal tissue material was obtained from therapeutic abortuses of 16-19 wk 
of gestation. Adrenal, brain, cardiac, kidney, liver, pancreatic, spleen, tes- 
tieular, and thymic tissues were identified, dissected free of surrounding tis- 
sues and immediately snap-frozen in liquid nitrogen. Samples intended for 
in situ hybridization analysis were fixed in 4% phosphate-buffered formal- 
dehyde. A stage IV neuroblastoma and a Wilms' tumor, obtained before initi- 
ation of chemotherapy, were treated similarly immediately after removal at 
surgery. Retinal samples were studied only by in situ hybridization because 
of paucity of material. 
Isolation  and Analysis of RNA 
Total RNA was extracted by the LiCl/urea-method (Auffray and Rougeon, 
1980) or'by the guanidine thiocyanate protocol (Chirgwin et al., 1979) from 
200  to  1,000  mg  of snap-frozen  tissue with  ultracentrifugation through 
cesium chloride cushions.  15-#g aliquots of total cellular RNA were frac- 
tionated in horizontal 1% agarose/formaldehyde gels, blotted onto synthetic 
nylon membrane (GeneScreen Plus), and hybridized under stringent condi- 
tions according to manufacturer's suggestions. The same filters were probed 
several times, with elution of previous probe between different experiments 
by incubating the filter for 30 min at  +600C in 96%  formamide with 10 
mM Tris-HCl, pH 7.4,  10 mM EDTA, pH 8.0. The 2.0-kbp ECO RI insert 
of the clone pNb-6 (Schwab et al.,  1983), carrying the second exon of the 
N-myc gene and  flanking DNA,  was  labeled as  such  for the  Northern 
hybridizations and for in situ hybridizations digested further with Sma I be- 
fore radioactive labeling to obtain fragments shorter than 600 bp. Similarly, 
the insert of the phigf2 eDNA clone for IGF-II mRNA (Bell et al.,  1984) 
was  generaWxi with Pst  I  and  for the in situ  hybridization experiments 
digested further with Pvu II to obtain fragments shorter than 500 bp. In in 
situ hybridizations, 100-790-bp bacteriophage X DNA fragments generated 
with Bgl I were used as negative control probe. The inserts were isolated 
and  purified  from  agarose  gels  by  isotachophoresis  (Ofverstedt  et  al., 
1984).  For  Northern  hybridizations,  the  inserts were  labeled with  32p. 
dCTP (PB.10205; Amersham International, Amersham, UK) and for in situ 
hybridizations  with 35S-dATP  (SJ.1304;  Amersham International) using 
nick-translation or the random priming method (Feinberg and Vogelstein, 
1983) to achieve specific activities of 1  x  109 epm/gg. After labeling, the 
probes were further extracted with phenol-chloroform, run through Sepha- 
dex G50 spin columns and ethanol precipitated to remove unincorporated 
nucleotides. 
In Situ Hybridizations 
The in situ hybridizations were carried out on 5-/~m-thick sections of for- 
maldehyde-fixed, paraffin-embedded material, using 3SS-dATP-labeled in- 
sert probes as previously described (Sandberg and Vuorio, 1987). In brief, 
the sections were mounted on acetylated microscope slides and deparaf- 
finized. To facilitate the access of the probes to the sections, the slides were 
treated with hydrochloric acid and proteinase K, followed by an additional 
acetylation step to prevent electrostatic binding of the probes to the sample. 
The hybridizations and washes were carried out under stringent conditions. 
The slides were then dipped into the autoradiography emulsion (NTB 3; Ko- 
dak Laboratory and Specialty Chemicals, Rochester, NY). After 2-4 wk ex- 
posure  times  at  +4°C,  the  in situ autoradiograms  were  developed  and 
stained with hematoxylin-eosin. Since regional grain densities are visually 
difficult to correlate with variation in cell density, grain counting was used. 
All the quantitative analyses were corrected a~cordingly; i.e. the results are 
expressed as grains per cell. 
lmmunohistochemicai Techniques 
Serial sections of the brain were immunostained with a polycionai rabbit 
antiserum to glial fibrillary acidic protein (Dakopatts A/S, Glostrup, Den- 
mark). Some sections of the eye were stained with an antiserum to myoglo- 
bin (Boehringer Mannheim GmbH, Mannheim, FRG). The bound primary 
antibodies were visualized using the avidin-biotin-immunoperoxidase tech- 
nique (Vector Laboratories, Inc., Burlingame, CA), with diaminobenzidine 
as the chromogen. 
Results 
Total  RNA  was  isolated from different tissues of several 
16-19-wk  human fetuses and analyzed for the content of 
N-myc and IGF-II mRNA. By Northern blotting, a strong 
3.0-kb N-myc mRNA band was seen in samples from fetal 
brain and weaker one in the kidney samples (Fig.  I). Only 
a very weak N-myc signal was observed in the other tissues 
tested and then only after a severalfold increase of exposure 
times. In comparison, the signal obtained with the IGF-II 
probe (Fig.  1,  60, 4.9, and 1.9 kb) was intense in samples 
from kidney and adrenal tissue. IGF-II mRNA was also seen 
in the liver, pancreas, and spleen. Interestingly, brain RNA 
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tionated  RNAs extracted from  16- 
19-wk human  fetal tissues  and hy- 
bridized  with  N-myc and  IGF-II 
probes. Typically, a clear N-myc sig- 
nal is obtained from brain and kidney 
RNAs.  Adrenal,  liver, spleen,  thy- 
mus, pancreas, and testis tissues gave 
only a very weak N-myc signal after 
a  severalfold increase  in  exposure 
times (not shown) while IGF-II tran- 
scripts can be detected in all these tis- 
sues. Note that the brain RNA shows 
a  weak but  definite IGF-II  signal. 
The RNAs loaded were visualized by 
ethidium  bromide  staining before 
Northern blotting (EtBr; showing the 
28S bands) to control the amount and 
integrity of  the RNA. The sizes of  the 
N-myc  and IGF-II-hybridizing RNAs 
are indicated in kilobases. 
gave a  low but definitive IGF-II signal.  Kidney and brain 
were therefore chosen for in situ hybridization analysis of 
cells responsible for the signals obtained in Northern hybrid- 
ization. 
The kidneys of second trimester human fetuses are rela- 
tively well differentiated. While early epithelial differentia- 
tion of the mesenchymal blastema still occurs in the outer 
cortical  areas,  the  inner  regions  contain  well-developed 
metanephric  blastema-derived  excretory  units  (glomeruli 
and proximal and distal convoluted tubules with the interven- 
ing loops of Henle) and collecting tubules derived from the 
ureteric bud. In in situ hybridization of the kidney, a great 
majority of the N-myc autoradiographic grains were located 
over the epithelially differentiating mesenchyme (i.e., mes- 
enchymal condensates, comma- and S-shaped bodies in the 
cortical parts [Fig. 2, a and hi) but signal was observed also 
over further differentiated epithelial structures like glomer- 
uli, convoluted tubules, and cells of the loops of Henle (Fig. 
2, c and d). The visual impression of signal over glomeruli 
in Fig. 2 d is accentuated as a result of the high cell density 
in  these  structures.  This conclusion becomes apparent in 
grain counting analysis shown in Fig. 3. Over the majority 
of the mesenchymal stromal cells only a background level of 
N-myc signal was observed, but scattered, intensely labeled 
single cells were also present, resulting in elevated average 
grain counts over the mesenchymal stromal cells.  In con- 
trast,  the  IGF-II autoradiographic  grains  were associated 
predominantly with the stromal and blastemal cells while the 
epithelial structures showed a relative lack of IGF-II signal 
(Fig. 2, e and  f). Control hybridization with labeled )~ phage 
DNA fragments gave a  very weak autoradiographic signal 
(Fig.  2, g  and h). 
The distribution of autoradiographic signal over different 
normal fetal kidney structures,  hybridized with the N-myc 
and IGF-II probes, is presented in Fig. 3. It should be noted 
that the N-myc and IGF-II grain counts are not directly com- 
parable with each other because of differences in the com- 
plexity and  specific radioactivity of the probes and  slight 
variation  in  autoradiography.  The  background  signal  ob- 
tained with the ~ phage DNA probe was less than two grains 
per cell and was randomly distributed over the kidney tissue 
(Fig. 2 f). 
The distribution of the IGF-II and N-myc in situ autoradio- 
graphic grains over the Wilms' tumor sections was very simi- 
lar to their distribution in the developing kidney. Fig. 4 shows 
a  section  of a  triphasic  Wilms'  tumor,  consisting  of the 
undifferentiated tumor tissue (labeled T in Fig. 4 a), incom- 
pletely formed epithelially differentiating elements (Fig. 4, 
c and g), a connective tissue stroma, and the adjacent normal 
kidney tissue  (labeled K  in  Fig.  4,  a  and  e).  The IGF-II 
mRNA signal was specific for the most primitive tumor cells 
with only background levels of signal over adjacent postnatal 
kidney tissue (Fig. 4, a-d). Within the tumor, islets of cells 
showing epithelial differentiation into tubular and glomeru- 
lar structures resembling the early differentiation stages of 
embryonic kidney showed a relative lack of  IGF-II autoradio- 
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Figure 3.  Summary of the in 
situ hybridization analysis of 
the kidney samples (see Fig. 
2)  showing relative levels of 
N-myc and IGF-II autoradio- 
graphic  grains  over the dis- 
tinct  structural  components. 
Columns  represent  (A)  the 
early  cortical  differentiation 
stages, (B) glomendi, (C) prox- 
imal convoluted tubules,  (D) 
distal part of the nephron, and 
(E) mesenchyme. Total values of average N-myc and IGF-II au- 
toradiographic grain counts per cell over these structures were nor- 
malized to 100 after subtracting background counts, and are ex- 
pressed as percentages found over each structure.  N-myc signal 
located over mesenchymal stroma (E, solid black bar) accounts for 
only 10% of total N-myc grain density, whereas the IGF-II signal 
(E, hatched bar) over mesenchyme accounts for 74% of  total IGF-II 
grain density, implying a relative lack of N-myc mRNA and an 
abundancy of  IGF-II mRNA in the stroma as compared to epithelial 
structures. 
graphic grains as compared to the primitive tumor cells (Fig. 
4,  c and d, arrows). N-myc expression displayed great re- 
gional variation and was not as clearly demarcated between 
the tumor and normal tissue (Fig. 4, e and f) while inside 
the tumor mass, clusters of cells with very high N-myc grain 
density were also observed (Fig. 4, g and h, arrows). In con- 
trast  to the IGF-II signal,  N-myc autoradiographic grains 
were present also over the islets of epithelially differentiating 
cells (Figs. 4,  c, d, and h, arrows). 
In the cerebrum, four definite zones are discernible at this 
stage of development (Figs. 5 and 6): (a) the highly cellular 
ependymal zone abounding to the ventricle; (b) the clearly 
less cellular subependymal zone; followed by (c) the sparsely 
cellular intermediate zone with radially oriented glial cells; 
and (d) the cortical plate with densely packed small neuro- 
blastic cells. This developmental gradient of differentiation 
of the cerebral cells with cell proliferation in the ventricular 
zone,  followed by outward migration and finally neuronal 
differentiation in the upper intermediate and cortical layers, 
is found between 5 and 34 wk of gestation (Herschkowitz, 
1988). In other words, in cross sections of human fetal cere- 
brum at 16-19 wk of gestation, all stages of neuroepithelial 
cell development and differentiation are present within the 
distinct zones. Thus, despite the limited availability of hu- 
man fetal material of different gestational ages for analysis, 
the histological sections that we have studied represent a pat- 
tern present for a relatively long time period of human fetal 
brain development. As the mitotic activity of the neuroepi- 
thelial cells is limited to the ependymal zone, all the other 
zones consist of postmitotic neuroepithelial cells. In situ hy- 
bridization  showed  N-myc  mRNA  throughout  all  these 
different structural layers. The autoradiographic grains were 
invariably found close to the perikarya, whereas in the neu- 
ropil only background levels of grains  were present.  The 
highest autoradiographic grain counts were obtained over the 
cells in the subependymal and intermediate zones (Fig.  5, 
a-d, and Fig. 6, black bars).  Somewhat fewer grains were 
detected in the ependymal zone adjacent to the lateral ventri- 
cles where the proliferation of the neuroepithelial cells takes 
place.  Cells migrating along the radial glia to the cortical 
plate gave a strong positive reaction with the N-myc probe 
(Fig. 5, a-d).  Thus, the highest level of N-myc expression 
was seen in the cells migrating to the cortical plate, and not 
in the proliferative cells of the ependymal zone. Some signal 
was also found over cells of the cortical plate (Fig. 5, b and 
d). These differences in grain distribution were confirmed 
by grain counting analysis (Fig. 6). 
For comparison, we performed in situ hybridization for 
N-myc mRNA on sections of a stage IV neuroblastoma sam- 
ple under identical conditions with the fetal brain sections. 
The tumor displayed great regional variation of the N-myc 
mRNA content (Fig. 7). High expression levels, clearly in 
excess of that observed in a simultaneous analysis of the hu- 
man fetal brain,  were found not only in the cells with the 
most primitive morphology, but also over some cells show- 
ing a degree of morphological differentiation, characterized 
by larger and paler nuclei (Fig. 7). Again, some cells with 
a more primitive morphology were apparently devoid of sig- 
nal.  No  c-myc expression  was  detected  in  the  tumor by 
Northern hybridization or by in situ hybridization in condi- 
tions where most fetal tissues gave a readily detectable signal 
(data not shown). 
IGF-II autoradiographic signal in the brain was weak in the 
ependymal zone adjacent to the lateral ventricles where a 
definitive N-myc autoradiographic signal was detected (Fig. 
5, e and g). In contrast, IGF-II signal in the subependymal 
and  intermediate  cell  layers  was  approximately threefold 
higher than in the ependymal zone (Figs. 5 and 6). A visual 
accentuation of IGF-II signal was associated with the transi- 
tional zone between the intermediate zone and cortical plate 
as compared to the intermediate zone (Figs. 5,fand h). How- 
ever, grain counting analysis showed that this was a visual 
artefact due to increased cell density in the intermediate zone 
just adjacent to the cortical plate (Fig. 6). The cortical plate 
again had a reduced IGF-II grain density (Fig. 5, f  and h). 
A summary of the quantitation of grain density in the differ- 
ent structural zones of the  17-wk fetal brain is presented in 
Fig.  6. 
Figure 2. Histology and autoradiography of sections of human fetal kidney hybridized with the N-myc probe (a-d), IGF-II probe (e and 
f), and bacteriophage • DNA control probe (g and h). N-myc signal is present particularly over cortical, epithelially differentiating mesen- 
thyme (a and b), but signal is present also over epithelial cells forming the distal part of the nephron (D) as well as cells of the developing 
glomeruli (G), and to lesser extent in the proximal convoluted tubules (labeled P in c and d). Most cells in the mesenchymal stroma show 
only background signal with some isolated cells (arrows) showing strong N-myc signal. IGF-II signal is located primarily over the mesen- 
chymal cells with a relative lack of signal over the tubular epithelial structures (labeled P and D) and glomeruli (labeled G in e and f). 
Very few grains are seen in the sections hybridized with the h-phage DNA fragments (g and h). The N-myc  and the control autoradiograms 
were exposed for 28 d and the IGF-II slides for 21 d. Bar, 50/zm. 
Hirvonen et al. N-myc and IGF-H in Human  Fetal Tissues  1097 Figure 4. In situ hybridization  of  IGF-II  (a-d) and N-myc mRNA (e-h) in a classical  triphasic  Wilms'  tumor, a, b, e, andfshow the peripheral 
expansion of the tumor against the adjacent kidney tissue. The tumor cells stain dark in the left-hand part of the photographs (T). The 
pale staining region in the middle is connective tissue, and the normal kidney parenchyma can be seen in the right-hand side (K). c, d, 
g, and h depict areas of the tumor showing all three components of differentiation typical for a triphasic tumor. Long arrows in c and 
d point to the tumor-derived structures showing some degree of epithelial differentiation. Note that these structures have a relative lack 
of IGF-II signal (c and d) as compared to condensates of primitive tumor cells (short arrows).  However, the epithelially differentiating 
structures express elevated levels of N-myc mRNA (long arrow in g and h). Within the mass of primitive tumor cells, scattered cells reacting 
very strongly with the N-myc probe are observed as a characteristic  pattern (short arrows in g and h). Compare also to the normal expression 
pattern of the developing kidney shown in Fig. 2. Bars: (a-d)  100 ~m; (e and f)  100/~m;  (g and h) 50/~m. 
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tions, an intense N-myc signal was obtained in the ganglionic 
cells as well as in the inner and outer nuclear layers. The 
grains were numerous over the cellular layers while the nerve 
fiber layers and the pigment layer displayed background lev- 
els of signal (Fig. 8, a and b). Interestingly, a weak but defini- 
tive N-myc signal was seen over a section of the extrinsic eye 
muscles (Fig. 9, a and b), identified as striated muscle mor- 
phologically and by antimyoglobin immunoperoxidase stain- 
ing (Fig. 9 c). 
Discussion 
In our screening of human fetal tissues,  abundant N-myc 
mRNA expression was found in the brain and the kidney by 
Northern hybridization in accordance with earlier studies 
(Grady  et  al.,  1987; Zimmerman  et  al.,  1986).  IGF-II 
mRNA was expressed by various fetal tissues including brain 
and kidney. These tissues as well as retina were chosen for 
the topographic analysis by in situ hybridization. In the kid- 
ney,  N-myc  mRNA  appeared  to  be  expressed  by  early 
epithelially differentiating mesenchyme as well as by further 
differentiated epithelial structures, i.e., the loops of Henle, 
convoluted tubules, and the developing glomeruli. In con- 
trast, the expression of IGF-II mRNA was largely confined 
to the stromal and blastemal cells of the kidney. In the de- 
veloping brain, N-myc mRNA was detected in all the differ- 
ent  developmental zones  while  IGF-II  mRNA  was  most 
abundant in the intermediate and subependymal zones. 
In the kidney, localization of N-myc mRNA into epitheli- 
ally differentiating mesenchymal cells originating from the 
metanephric blastema implies that high level N-myc  expres- 
sion is not limited to cells of neuroectodermal origin only. 
It is possible, though unproven, that the induction of differ- 
entiation  of the  mesenchymal blastema  cells  (Lehtonen, 
1976; Saxtn et al., 1986) is associated with the induction of 
high level N-myc expression. Alternatively, the expression of 
N-myc is elevated already in the undifferentiated blastema 
cells, but, at some point during development, the expression 
ceases in the mesenchymal, stromally differentiating cells. 
To distinguish between these possibilities, in situ hybridiza- 
tion  studies  are  needed  in  suitable  experimental  systems 
where the inductive events can be observed and manipulated 
such as in the transfilter induction model (Ekblom,  1984; 
Lehtonen and Saxtn,  1986;  Sariola,  1984). 
The blastema-derived cells also give rise to Wilms' tumors 
where high N-myc expression levels are detected (Nisen et 
al., 1986). It has been claimed that the expression of IGF-II 
mRNA by mesenchymal cells presents a form of paracrine 
growth factor expression as most of the IGF-II immunoreac- 
tivity is not found in the mesenchymal or connective tissues, 
but it is present in the kidney in the renal tubular ceils (Han 
et al., 1987).  Our finding of the complementary expression 
of the IGF-II and N-myc mRNAs in the developing kidney 
stroma  and  epithelially differentiating structures,  respec- 
tively, is thus compatible with the idea that the expression 
of IGF-II by blastemal and stromal cells provides a paracrine 
stimulus for the growth and differentiation of the epithelial 
structures,  a  stimulus that could also  regulate N-myc ex- 
pression. 
Our in situ hybridization results in a  triphasic pediatric 
Wilms' tumor are similar to our findings in the developing 
normal kidney. IGF-II expression in the tumor is decreased 
in cells showing features of epithelial differentiation while 
these  abortive  epithelial  structures  resembling the  corre- 
sponding  early  differentiation stages  of the  normal  em- 
bryonic kidney still expressed N-myc mRNA. These results 
suggest a downregulation of IGF-II mRNA expression in the 
epithelially differentiating structures, which is analogous to 
the findings in normal embryonic kidney cells. Also, N-myc 
expression in the Wilms' tumor occurs in a pattern predicted 
by N-myc expression in the normal kidney: in addition to 
most primitive blastemal cells, those undergoing epithelial 
differentiation also show N-myc expression. Therefore, the 
expression of IGF-II and N-myc mRNAs in Wilms' tumor 
may not be caused by a deregulation of the mechanisms con- 
trolling their expression, but it is likely to reflect the normal 
developmental pattern of gene expression, which is main- 
rained because of a failure of complete differentiation of the 
tumor cells. 
The presence of N-myc mRNA in cells of the intermediate 
zone and cortical plate of fetal brain is of particular interest 
because these cells have ceased to proliferate, and yet they 
express N-myc mRNA. Since N-myc mRNA has a short half- 
life of ~20 min (Stanton and Bishop, 1987) and the migra- 
tion of cells into the cortical plate takes 4-6 d (Nowakowski 
and Rakic, 1981), we exclude the possibility that the signal 
seen in the nonmitotic cell layers represents mRNA main- 
rained from transcription within the ependymal zone. This 
implies that the expression of N-myc is not associated with 
proliferative activity only. On the other hand, N-myc expres- 
sion decreased in the cortical plate suggesting an association 
of this downregulation with differentiation. This finding is in 
line with experimental data obtained from retinolc acid-in- 
duced differentiation of primitive neuroblasts that showed 
decreasing levels of N-myc mRNA before morphological 
differentiation (Thiele et al., 1985; Amatruda et al., 1985). 
However,  a growth arrest was also detected in the retinoic 
acid-differentiated cells, which thus partly disables the as- 
sessment of the eventual differential effects  of decreasing 
N-myc expression on proliferation and differentiation of the 
cells. Our estimate for the level of N-myc expression differs 
somewhat from that obtained by Grady et al. (1987) in that 
we find slight accentuation of N-myc signal per cell in the 
intermediate layers when compared with ependymal and cor- 
tical  layers.  However,  eventual  differences  of  the  brain 
regions studied by Grady et al. and by us disable direct com- 
parison of the results. Similarly to Grady et al., we detect 
elevated N-myc mRNA in the inner nuclear and ganglionic 
cell layers of the fetal retina. 
The presence of N-myc mRNA in the striated extrinsic eye 
muscle may reflect a role for N-myc during normal myogene- 
sis since N-myc mRNA has been detected also in the cardiac 
muscle in developing mice (Zimmerman et al., 1986). Again, 
it may reflect the fact that cranial muscles, unlike other stri- 
ated musculature, arise from the neural crest, being thus of 
neuroectodermal origin. Interestingly, Garson et al. (1986) 
have reported amplification of N-myc in a recurrent rhabdo- 
myosarcoma arising as a palatal mass; i.e. in structures de- 
rived from the neural crest. This may indicate similarities 
between cranial rhabdomyosarcomas and some other neural 
crest-derived tumors in their tendency to gain a growth ad- 
vantage through increased dosage of the N-myc gene. 
The finding of N-myc expression not only in the most 
Hirvonen et al. N-myc and IGF-II in Human Fetal ~ssues  1099 The Journal  of  Cell  Biology,  Volume 108,  1989  l  I00 Figure 6.  Grain counting analysis  of the in situ hybridization results  in human fetal brain with the N-myc, IGF-II, and control probes. 
The photomicrograph shows a GFAP-stained  sagittal section of human fetal brain at 17 gestational  wk. The zones marked correspond to 
the columns given in the upper part of the figure: EPZ, ependymal zone; S-EPZ, subependymal zone;/Z, intermediate  zone; CDZ, transi- 
tional zone between the intermediate  layer and the cortical plate,  with  increasing  cell density; and CTX, cortical plate.  The radial  glia 
directing the migration of neuroepithelial  cells  from the ependymal zone to the cortical plate is apparent from the GFAP-stained section. 
Bar,  200/~m. 
primitive neuroblastoma cells but also in cells showing some 
degree of neuronal differentiation bears a  direct analogy to 
our results of  hybridization in the fetal brain samples because 
expression  was  detected  also  in  cells  that  had  undergone 
some degree of neural differentiation, as judged by morphol- 
ogy. An earlier report by Schwab et al.  (1984) documented 
the highest N-myc expression in the most primitive portions 
of the neoplasm. However, the biological variation of neuro- 
blastoma tumors is great and regional variations in them may 
result from subtle differences in gene expression not appar- 
ent morphologically. 
Another interesting finding obtained in the present study 
Figure 5.  Bright corresponding dark field photomicrographs of in situ hybridization of human fetal brain sections  with the N-myc (a-d), 
IGF-II (e-h), and bacteriophage X probes (i and j). The ependymal region is shown in the left column and the cortical surface in the right 
column. Expression of N-myc mRNA is apparent throughout the brain (b and d).  The proliferative  cells  in the ependymal zone (EPZ) 
show fewer autoradiographic  grains than the subependymal layers (S-EPZ) (a and c).  The IGF-II mRNA is almost totally  absent  from 
the ependymal zone (e and g) and present predominantly in the cells of the intermediate  zone (/Z). The apparent accentuation of the IGF-II 
signal between  the intermediate  zone and the inner margin of the cortical plate  (CTX) is a visual artefact caused by local increase  in cell 
density (see Fig.  6).  The few grains in Fig.  5 g adjacent to the brain tissue  represent  nonspecific  binding of the probe to the margins of 
the tissue section, an artefact seen in some sections even with the control probe. Bars: (a, c, e, g, and i) 100/,m; (b, d,f, h, and j) 100 #m. 
Hirvonen et al. N-myc and IGF-H in Human Fetal Tissues  1101 Figure 7. Bright field (a) and dark field (b) photomicrographs of a section of a stage IV neuroblastoma hybridized with the N-myc probe. 
The heterogeneity of N-myc expression by tumor cells is apparent. N-myc autoradiographic grains, best visualized in dark field microscopy 
(b), are located over primitive tumor cells (short arrow) as well as cells displaying morphological features of neuronal differentiation such 
as increased cell size, and large, paler nuclei (long arrows). In addition,  some primitive appearing cells are relatively devoid of signal 
(short arrows). Bar,  100 #m. 
is the  low but definitive IGF-II mRNA signal  in  the  fetal 
brain. This can very likely be accounted for by a better sensi- 
tivity in our study using a nearly full-length cDNA probe, 
Figure 8. A section of  fetal retina sample hybridized with the N-myc 
probe shows abundant signal over all cell layers. Because of  the sec- 
tion thickness, the background is shown on the fight in a separate 
picture focused on the background. (1) Outer nuclear layer; (2) in- 
ner nuclear layer; (3) ganglion cell layer. Bar, 20/zm. 
whereas in an earlier study by Han et al. (1987) short oligo- 
nucleotide probes were used.  Our analysis, then, gives the 
first spatial information on IGF-II synthesis in the human fe- 
tal brain. It was noteworthy to find different patterns of distri- 
bution of N-myc and IGF-II mRNAs in the ependymal and 
subependymal  zones.  Although  the  levels  of  IGF-II ex- 
pressed must be low,  IGF-II mRNA has been shown to be 
present in the developing rat central nervous system (Brown 
et al.,  1986;  Sara et al.,  1986;  Rotwein et al.,  1988),  and 
a  physiological  role  for  IGF-II as  neuroregulator  and/or 
brain growth factor has been suggested. The absence of the 
IGF-II  mRNA signal in the proliferative ependymal zone and 
its  appearance  in  the  migratory  and  differentiating  zones 
agrees well with this view. Our results are also consistent 
with the finding that cultured astroglial but not neuronal cells 
produce IGF-II (Rotwein et al.,  1988) as IGF-II mRNA is 
most abundant in the intermediate zone, where astroglia is 
the  prevailing  cell  type.  A  further  complexity  of IGF-II 
mRNA expression has recently emerged from studies of the 
differential splicing pattern of IGF-II transcripts in different 
tissues (Irminger et al.,  1987). The two promoters that have 
been found in  the human IGF-II gene could very well be 
regulated in a  tissue-specific manner,  a matter that will be 
best resolved in studies of hybrid gene constructs in trans- 
genic mice. 
Mechanisms responsible for the emergence of childhood 
neoplasms present a problem to pathologists, embryologists, 
and basic scientists.  Some common childhood  neoplasms, 
such as neuroblastoma and Wilms' tumor, appear to repre- 
sent a failure of proper maturation of their tissues of origin 
with a variable degree of differentiation. Molecular analysis 
of these  tmnors  has  revealed  specific  deletions  of chro- 
mosomal DNA that may be associated with an activation of 
recessive oncogenes in,  for example, neuroblastomas, ret- 
inoblastomas, and Wilms' tumors (for review,  see Cavenee 
and Hansen, 1986; Cavenee et al., 1986). It has been postu- 
lated that the recessive oncogenes act as suppressor genes 
downregulating  the  expression  of  "transforming"  genes, 
which are active during embryogenesis but suppressed dur- 
ing differentiation (Comings,  1973;  Klein,  1987).  Loss of 
The Journal of Cell Biology,  Volume  108, 1989  1102 Figure 9. N-myc autoradiographic grains over a section of the extrinsic ocular striated musculature (a and b), identified morphologically 
and by immunostaining for myoglobin (c).  Bar, 100/xm. 
both copies of these genes may lift  the  suppression,  thus 
maintaining  the  expression  of the  transforming  genes  and 
leading to tumorigenesis.  Such events might be fundamental 
in  the  genesis  of,  for  example,  Wilms'  tumor  displaying 
N-myc oncogene and IGF-II growth factor overexpression. 
Comparative analysis of fetal tissues and embryonally de- 
rived tumors may illuminate these questions. Since fetal tis- 
sues, unlike most tumors expressing the N-myc gene, display 
coexpression of the myc family genes, it will be interesting 
to extend these studies to the localization of c-myc and L-myc 
transcripts  in the same tissues;  these ongoing experiments 
will probably help to clarify the  significance  of each myc 
gene  and  their  regulation  in  cellular  proliferation  and 
differentiation during  normal  human  fetal development. 
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